Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Ando

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Scientific Reports|June 24, 2026
Possible involvement of the mesenchymal cell marker Meflin in regeneration after retinal injuryDaishi Okuda, Shinji Mii, Yuki Miyai, et al.
Journal of Cardiovascular Computed Tomography|July 2, 2025
Incremental prognostic value of aortic tortuosity index in older patients undergoing transcatheter aortic valve replacementTuan Hoang Nguyen, Ryota Ando, Kazuyuki Yamaguchi, et al.
Brain Pathology (Zurich, Switzerland)|November 10, 2025
Meflin/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progressionYukihiro Shiraki, Tomotsugu Kurauchi, Akitoshi Hara, et al.
Pathology International|January 12, 2022
Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancerRyosuke Ichihara, Yukihiro Shiraki, Yasuyuki Mizutani, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|May 7, 2021
Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacityAkitoshi Hara, Katsuhiro Kato, Toshikazu Ishihara, et al.
The American Journal of Pathology|February 4, 2026
Increased Meflin expression in cancer-associated fibroblasts restrains tumor cell proliferation and shapes vessel-rich stroma in triple-negative breast cancerAkihiro Sakai, Yuki Miyai, Yukihiro Shiraki, et al.
Journal of Cardiology Cases|August 4, 2022
Recurrent fulminant non-rheumatic streptococcal myocarditis proven by endomyocardial biopsy and autopsyHiroaki Hiraiwa, Ryota Morimoto, Ryota Ando, et al.
The Journal of Pathology|October 5, 2023
Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreasRyota Ando, Yukihiro Shiraki, Yuki Miyai, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|August 13, 2024
Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosisToshikazu Ishihara, Katsuhiro Kato, Kotaro Matsumoto, et al.
Oncogene|October 21, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcomaNobutoshi Esaki, Tomoka Sakoda, Ryota Ando, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Scientific Reports|June 24, 2026
Possible involvement of the mesenchymal cell marker Meflin in regeneration after retinal injuryDaishi Okuda, Shinji Mii, Yuki Miyai, et al.
Journal of Cardiovascular Computed Tomography|July 2, 2025
Incremental prognostic value of aortic tortuosity index in older patients undergoing transcatheter aortic valve replacementTuan Hoang Nguyen, Ryota Ando, Kazuyuki Yamaguchi, et al.
Brain Pathology (Zurich, Switzerland)|November 10, 2025
Meflin/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progressionYukihiro Shiraki, Tomotsugu Kurauchi, Akitoshi Hara, et al.
Pathology International|January 12, 2022
Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancerRyosuke Ichihara, Yukihiro Shiraki, Yasuyuki Mizutani, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|May 7, 2021
Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacityAkitoshi Hara, Katsuhiro Kato, Toshikazu Ishihara, et al.
The American Journal of Pathology|February 4, 2026
Increased Meflin expression in cancer-associated fibroblasts restrains tumor cell proliferation and shapes vessel-rich stroma in triple-negative breast cancerAkihiro Sakai, Yuki Miyai, Yukihiro Shiraki, et al.
Journal of Cardiology Cases|August 4, 2022
Recurrent fulminant non-rheumatic streptococcal myocarditis proven by endomyocardial biopsy and autopsyHiroaki Hiraiwa, Ryota Morimoto, Ryota Ando, et al.
The Journal of Pathology|October 5, 2023
Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreasRyota Ando, Yukihiro Shiraki, Yuki Miyai, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|August 13, 2024
Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosisToshikazu Ishihara, Katsuhiro Kato, Kotaro Matsumoto, et al.
Oncogene|October 21, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcomaNobutoshi Esaki, Tomoka Sakoda, Ryota Ando, et al.
Pageof 4